Cargando…

Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study

BACKGROUND: Prior studies suggested low density lipoprotein particle (LDLP) size is a predictor of atherosclerosis. Knowledge of effects of lipid lowering drugs on lipoprotein subclasses is useful. We treated subjects with hyperlipidemia sequentially with statins and fibrates, the 2 main classes of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Sammy Y, Mancini, GB John, Ignaszewski, Andrew, Frohlich, Jiri
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586010/ https://www.ncbi.nlm.nih.gov/pubmed/18957124 http://dx.doi.org/10.1186/1472-6904-8-10

Ejemplares similares

Anti-atherogenic effects of fibrates in type 2 diabetes
por: Barter, Philip
Publicado: (2001)

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
por: Yanai, Hidekatsu, et al.
Publicado: (2022)

Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
por: Tenenbaum, Alexander, et al.
Publicado: (2012)

The Ratio of Unesterified/esterified Cholesterol is the Major Determinant of Atherogenicity of Lipoprotein Fractions
por: Bagheri, Babak, et al.
Publicado: (2018)

High Density Lipoprotein Particle Size in Children: Relation to Atherogenic Dyslipidemia
por: Numata, Michio
Publicado: (2004)

Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile
por: Corey, Kathleen E, et al.
Publicado: (2014)

VLDL receptor gene therapy for reducing atherogenic lipoproteins
por: Krauss, Ronald M., et al.
Publicado: (2023)

Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action
por: Nagao, Manabu, et al.
Publicado: (2018)

Atherogenic dyslipidemia
por: Manjunath, C. N., et al.
Publicado: (2013)

The Effect of Untraditional Lipid Parameters in the Development of Coronary Artery Disease: Atherogenic Index of Plasma, Atherogenic Coefficient and Lipoprotein Combined Index
por: Çelik, Ersin, et al.
Publicado: (2021)

Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects
por: Cartolano, Flávia De C., et al.
Publicado: (2017)

Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles
por: Syed, Shahan, et al.
Publicado: (2021)

Predictive value of atherogenic index of plasma and atherogenic index of plasma combined with low-density lipoprotein cholesterol for the risk of acute myocardial infarction
por: Chen, Min, et al.
Publicado: (2023)

Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins
por: Sakamoto, Kentaro, et al.
Publicado: (2015)

Is Lipid Accumulation Product Associated with an Atherogenic Lipoprotein Profile in Brazilian Subjects?
por: Cartolano, Flavia De Conti, et al.
Publicado: (2018)

The LipoGlo reporter system for sensitive and specific monitoring of atherogenic lipoproteins
por: Thierer, James H., et al.
Publicado: (2019)

Investigating the Atherogenic Risk of Lipoprotein(a) in Type 2 Diabetic Patients
por: Peela, Jagannadha R, et al.
Publicado: (2018)

Long-term fasting improves lipoprotein-associated atherogenic risk in humans
por: Grundler, Franziska, et al.
Publicado: (2021)

AMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE(−/−) mice
por: Ma, Ang, et al.
Publicado: (2017)

On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety
Publicado: (1995)

Prevalence and Predictors of Atherogenic Serum Lipoprotein Dyslipidemia in Women with Obstructive Sleep Apnea
por: Xia, Yunyan, et al.
Publicado: (2017)

Anti-Atherogenic Properties of Allium ursinum Liophylisate: Impact on Lipoprotein Homeostasis and Cardiac Biomarkers in Hypercholesterolemic Rabbits
por: Bombicz, Mariann, et al.
Publicado: (2016)

Atherogenic Factors and Their Epigenetic Relationships
por: Fernandez, Ana Z., et al.
Publicado: (2010)

Approach to Reduction of Blood Atherogenicity
por: Orekhov, Alexander N., et al.
Publicado: (2014)

Stress erythropoiesis in atherogenic mice
por: Sánchez, Ángela, et al.
Publicado: (2020)

Genetic Determinants of Atherogenic Indexes
por: Texis, Tomas, et al.
Publicado: (2023)

Anti-atherogenic properties of vitamin E, aspirin, and their combination
por: Chai, Sheau C., et al.
Publicado: (2018)

Annexin A6 Polymorphism Is Associated with Pro-atherogenic Lipid Profiles and with the Downregulation of Methotrexate on Anti-Atherogenic Lipid Profiles in Psoriasis
por: Zhang, Fuxin, et al.
Publicado: (2022)

Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
por: Tenenbaum, Alexander, et al.
Publicado: (2006)

Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin
por: Srisawasdi, Pornpen, et al.
Publicado: (2021)

Atherogenic index of plasma: A valuable novel index to distinguish patients with unstable atherogenic plaques
por: Khosravi, Arezoo, et al.
Publicado: (2022)

Evaluation of atherogenic lipoprotein-cholesterol to HDL cholesterol ratio as a prognostic test for ST-segment elevation myocardial infarction
por: Li, Jia-Yong, et al.
Publicado: (2021)

Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet – the RESOLVE trial
por: Dutheil, Frédéric, et al.
Publicado: (2014)

Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Reveals a More Atherogenic Profile
por: Tom, Wynnis L., et al.
Publicado: (2016)

Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal study
por: Lin, Jennie, et al.
Publicado: (2015)

Author Correction: The LipoGlo reporter system for sensitive and specific monitoring of atherogenic lipoproteins
por: Thierer, James H., et al.
Publicado: (2020)

Conformationally Altered C-Reactive Protein Capable of Binding to Atherogenic Lipoproteins Reduces Atherosclerosis
por: Pathak, Asmita, et al.
Publicado: (2020)

Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation
por: Schnitzler, Johan G., et al.
Publicado: (2020)

Effects of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on Lipoprotein Atherogenicity
por: Farràs, Marta, et al.
Publicado: (2020)

Anorexia Nervosa Is Associated with a Shift to Pro-Atherogenic Low-Density Lipoprotein Subclasses
por: Stadler, Julia T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m08u0noigbk3dmio2nl1cpmk6g